Universal Ibogaine Inc. (TSXV:IBO)
Canada · Delayed Price · Currency is CAD 0.0250
0.00 (0.00%)
Aug 1, 2025, 3:42 PM EDT
FARO Technologies Revenue
Universal Ibogaine had revenue of 700.92K CAD in the quarter ending April 30, 2025, with 30.61% growth. This brings the company's revenue in the last twelve months to 2.06M, down -11.68% year-over-year. In the fiscal year ending July 31, 2024, Universal Ibogaine had annual revenue of 2.33M with 126.32% growth.
Revenue (ttm)
2.06M
Revenue Growth
-11.68%
P/S Ratio
3.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 2.33M | 1.30M | 126.32% |
| Jul 31, 2023 | 1.03M | -40.82K | -3.81% |
| Jul 31, 2022 | 1.07M | - | - |
| Jul 31, 2021 | - | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.58B |
| Curaleaf Holdings | 1.89B |
| WELL Health Technologies | 990.34M |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 179.08M |
| Extendicare | 1.47B |